NEWS

RibonEx, the first off-the-shelf TargetEx product, is now available to everyone

We have launched our first finished product, the RNase inhibitor RibonEx.

As part of TargetEx Biosciences Ltd's new market strategy, we are committed to supporting our partners not only with custom services, but also with premium off-the-shelf products. We have reached a very important milestone in this strategy as we have successfully launched the RibonEx RNase inhibitor.

RibonEx RNase inhibitor is able to inhibit a wide range of RNases, including RNases A, B and C, at temperatures up to 67°C for 30 minutes. The mammalian placenta-derived enzyme, produced in Hi Five™ insect cells is available in our range with an outstandingly high purity and ISO 9001 quality assurance certification.

The protein is available in NaCl and KCl buffered form in 2,500U and up to 10,000U, according to the user's requirements. We are happy to provide samples to all interested parties. Simply click on the 'request a sample' link under the products menu on our website.

The RibonEx RNase inhibitor is a big step for us, but it is only the first in a series of proteinS we are planning to introduce. To keep track of our constantly updated offers, please visit our website regularly or subscribe to our mailing list.

More news mentions & press releases

Fast, Reliable, and EURL-Validated: Meet the TargetEx ASFV qPCR Diagnostic Kit

Our first molecular diagnostic kit demonstrated excellent diagnostic performance during independent evaluation by EURL-ASFV (INIA-CSIC).

Introducing the TargetEx Bulk Offer

Save today, secure tomorrow and grow together!

New milestone in drug development

Promising compound has reached clinical phase with TargetEx contribution